A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
Authors:
Open Access
- 9 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 963072
Abstract
Background: Long non-coding RNAs (lncRNAs) play an essential role in the occurrence and prognosis of tumors, and it has great potential as biomarkers of tumors. However, the roles of Necroptosis-related lncRNA (NRLs) in Head and neck squamous cell carcinoma (HNSCC) remain elusive.Methods: We comprehensively analyzed the gene expression and clinical information of 964 HNSCC in four cohorts. LASSO regression was utilized to construct a necroptosis-related lncRNA prognosis signature (NLPS). We used univariate and multivariate regression to assess the independent prognostic value of NLPS. Based on the optimal cut-off, patients were divided into high- and low-risk groups. In addition, the immune profile, multi-omics alteration, and pharmacological landscape of NLPS were further revealed.Results: A total of 21 NRLs associated with survival were identified by univariate regression in four cohorts. We constructed and validated a best prognostic model (NLPS). Compared to the low-risk group, patients in the high group demonstrated a more dismal prognosis. After adjusting for clinical features by multivariate analysis, NLPS still displayed independent prognostic value. Additionally, further analysis found that patients in the low-risk group showed more abundant immune cell infiltration and immunotherapy response. In contrast, patients in the high-risk group were more sensitive to multiple chemotherapeutic agents.Conclusion: As a promising tool, the establishment of NLPS provides guidance and assistance in the clinical management and personalized treatment of HNSCC.Keywords
This publication has 51 references indexed in Scilit:
- Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancerCell Death & Differentiation, 2016
- Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancerOncogenesis, 2015
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targetsNature Communications, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- A significance test for the lassoThe Annals of Statistics, 2014
- Simultaneous discovery of rare and common segment variantsBiometrika, 2012
- Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular CarcinomaJournal of Clinical Oncology, 2011
- Gene set enrichment analysis: performance evaluation and usage guidelinesBriefings in Bioinformatics, 2011
- GenePattern 2.0Nature Genetics, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005